Genzyme submits applications to FDA and EMA for approval of LEMTRADA™ (alemtuzumab) for multiple sclerosis Business Wire, 12 Jun 2012 Accessed on 8 Aug 2012 from http://www.businesswire.com/news/genzyme/20120611006439/en. CommentRecommendBookmarkWatch